Clean Mobility: EC tables proposal on car emissions testing in real driving conditions
In response to a ruling by the General Court, the Commission proposes to reinsert certain aspects of Real Driving Emissions testing (RDE) into legislation to be adopted by the European Parliament and Council.
The European Commission has been very active in promoting air quality, fighting climate change and supporting a shift to clean mobility. Actions include new and more reliable emissions tests in real driving conditions as well as an improved laboratory test. These efforts are already yielding results. New types of diesel vehicles tested both in the laboratory and on the road under real-world conditions and placed on the market since September 2017 emit significantly less than older types of diesel vehicles.
In December 2018, the General Court annulled some of the provisions of EU legislation on Real Driving Emissions testing. The Court judged that so-called “conformity factors” should not have been adopted via comitology procedure, but via ordinary legislative procedure. The annulment is of a partial nature and does not affect the actual RDE test procedure, which remains in force and must still be conducted at type-approval.
The Court delayed the effects of the partial annulment until February 2020 to give time to the Commission to implement the judgment. To avoid legal uncertainty on the type approvals granted since September 2017 – when the RDE test procedure became mandatory – the Commission proposes to reinsert the same conformity factors into the legal text. The Commission is tabling the legal proposal via the ordinary legislative procedure, as requested by the General Court. The Commission thereby acts to ensure the necessary legal certainty for national authorities, industry and consumers.
Once adopted by the European Parliament and the Council, the Regulation will be directly applicable in all Member States and will become mandatory 3 days after publication in the EU Official Journal.
The legal framework for RDE was developed in comitology procedure, where the Commission makes a proposal to national experts, which may amend the proposal before voting. The text is then submitted to the European Parliament and Council for endorsement or rejection. This was the procedure followed for the adoption of RDE Act 2 (Regulation 2016/646), where the compromise found by Member State experts on 28 October 2015 was subsequently endorsed by the European Parliament and the Council.
In December 2018, the General Court annulled some of the provisions of RDE Act 2, namely the so-called “conformity factors”. Conformity factors establish the allowed discrepancy between the regulatory emissions limit that is tested in laboratory conditions and the values of the RDE procedure when the car is driven by a real driver on a real road, with the aim to progressively reduce this discrepancy.
In its ruling, the General Court did not question the technical necessity of the conformity factors, but considered that the Commission exceeded its implementing powers when establishing the RDE conformity factors through comitology instead of co-decision legislation (= ordinary legislative procedure). The Commission lodged an appeal against the General Court judgement in February 2019 on the grounds that it disagrees with the Court's legal assessment that the Commission exceeded its implementing powers.
For More Information
- FAQs on the recent proposal concerning RDE testing
- Legislative proposal concerning RDE testing
- FAQs: Testing of emissions from cars
- Press release: Air quality - Commission takes action to protect citizens from air pollution
- FAQs: New EU type-approval rules for safer and cleaner cars
Latest News from
EC opens investigation into possible anti-competitive conduct of Amazon18/07/2019 15:25:00
The EC has opened a formal antitrust investigation to assess whether Amazon's use of sensitive data from independent retailers who sell on its marketplace is in breach of EU competition rules.
Turkish drilling activities in the Eastern Mediterranean16/07/2019 15:25:00
The Council adopted the following conclusions on the Turkish drilling activities in the Eastern Mediterranean.
Four new substances added to the Candidate List16/07/2019 13:43:00
The Candidate List of substances of very high concern (SVHCs) for authorisation now contains 201 substances.
Imports of hormone-free beef: EU-US agreement confirmed16/07/2019 11:43:00
The Council has adopted a decision on the signing of an agreement between the EU and the US on the allocation to the US of a share in the TRQ for high quality beef regarding the importation of beef from animals not treated with certain growth-promoting hormones.
EIOPA consults on the harmonisation of national insurance guarantee schemes15/07/2019 12:32:00
Tthe European Insurance and Occupational Pension Authority (EIOPA) has launched a consultation on its Advice on the harmonisation of national insurance guarantee schemes across the Member States of the European Union.
EU-U.S. trade talks: milestone reached in mutual recognition on pharmaceuticals12/07/2019 15:25:00
The EU and the USA have delivered on a significant element of the Joint Statement agreed by Presidents Juncker and Trump in July 2018. The positive transatlantic trade agenda established in the Joint Statement includes a commitment from both sides to reduce barriers and increase trade in a range of sectors, including pharmaceuticals.
Airbnb cooperates with EC and EU consumer authorities improving the way it presents offers12/07/2019 13:25:00
The EC has announced that, as a result of negotiations with Airbnb, the platform has improved and fully clarified the way it presents accommodation offers to consumers, which is now in line with the standards set in EU consumer law.
European Institute of Innovation and Technology: EC proposes strategy for 2021-202712/07/2019 11:33:00
The EC has proposed an update of the legal base of the European Institute of Innovation and Technology (EIT) as well as its new Strategic Innovation Agenda for 2021-2027.
EC approves GlaxoSmithKline's acquisition of Pfizer's Consumer Health Business with conditions11/07/2019 15:25:00
The EC has approved, under the EU Merger Regulation, the acquisition of Pfizer's Consumer Health Business by GlaxoSmithKline. The decision is conditional upon the global divestment of Pfizer's topical pain management business carried out under the ThermaCare brand.